PPARG and obesity disorder: In this respect, it is well known that the decreased expression of peroxisome proliferator-activated receptor gamma (PPARγ) inhibits adipogenesis, compensated by AT hypertrophy in obesity, increases ectopic fat accumulation, and increases the risk of IR [93].